Andrew D. Dickinson - 12 Feb 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Signature
/s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson
Issuer symbol
GILD
Transactions as of
12 Feb 2025
Net transactions value
-$4,812,368
Form type
4
Filing time
13 Feb 2025, 21:13:45 UTC
Previous filing
06 Feb 2025
Next filing
19 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise $4,965,232 +77,691 +45% $63.91 248,914 12 Feb 2025 Direct F1
transaction GILD Common Stock Options Exercise $1,516,056 +26,175 +11% $57.92 275,089 12 Feb 2025 Direct F1
transaction GILD Common Stock Options Exercise $1,259,232 +15,600 +5.7% $80.72 290,689 12 Feb 2025 Direct F1
transaction GILD Common Stock Options Exercise $1,520,353 +18,210 +6.3% $83.49 308,899 12 Feb 2025 Direct F1
transaction GILD Common Stock Sale $14,073,241 -137,676 -45% $102.22 171,223 12 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -77,691 -81% $0.000000 17,929 12 Feb 2025 Common Stock 77,691 $63.91 Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -26,175 -25% $0.000000 78,515 12 Feb 2025 Common Stock 26,175 $57.92 Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -15,600 -100% $0.000000 0 12 Feb 2025 Common Stock 15,600 $80.72 Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -18,210 -100% $0.000000 0 12 Feb 2025 Common Stock 18,210 $83.49 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
F2 The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.